RUA Life Sciences plc (AIM:RUA)
12.00
0.00 (0.00%)
May 13, 2025, 4:35 PM GMT+1
Revenue by Product
Fiscal year is April - March.
Year Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
---|---|---|---|---|---|
Contract Manufacture | 1.68M |
Log In |
Log In |
Log In |
Log In |
Contract Manufacture Growth | 3.32% |
Log In |
Log In |
Log In |
Log In |
Biomaterials | 496.00K |
Log In |
Log In |
Log In |
Log In |
Biomaterials Growth | -10.47% |
Log In |
Log In |
Log In |
Log In |
Vascular | 16.00K |
Log In |
Log In |
Log In |
Log In |
RUA Medical Devices | - |
Log In |
Log In |
Log In |
Log In |
RUA Medical Devices Growth | - |
Log In |
Log In |
Log In |
Log In |
RUA Life Sciences | - |
Log In |
Log In |
Log In |
Log In |
RUA Life Sciences Growth | - |
Log In |
Log In |
Log In |
Log In |
Royalty | - |
Log In |
Log In |
Log In |
Log In |
Royalty Growth | - |
Log In |
Log In |
Log In |
Log In |
License | - |
Log In |
Log In |
Log In |
Log In |
License Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is April - March.
Year Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
---|---|---|---|---|---|
United States | 1.95M |
Log In |
Log In |
Log In |
Log In |
United States Growth | -0.21% |
Log In |
Log In |
Log In |
Log In |
Switzerland | 158.00K |
Log In |
Log In |
Log In |
Log In |
Switzerland Growth | -5.95% |
Log In |
Log In |
Log In |
Log In |
Israel | 50.00K |
Log In |
Log In |
Log In |
Log In |
Israel Growth | 4.17% |
Log In |
Log In |
Log In |
Log In |
Italy | 38.00K |
Log In |
Log In |
Log In |
Log In |
Italy Growth | 153.33% |
Log In |
Log In |
Log In |
Log In |
United Kingdom | - |
Log In |
Log In |
Log In |
Log In |
Europe | - |
Log In |
Log In |
Log In |
Log In |
Europe Growth | - |
Log In |
Log In |
Log In |
Log In |
Rest of the World | - |
Log In |
Log In |
Log In |
Log In |
Rest of the World Growth | - |
Log In |
Log In |
Log In |
Log In |